Try our Advanced Search for more refined results
Regeneron Pharmaceuticals Inc.
- June 02, 2022 Rising Star: O'Melveny's Stephen McIntyre
- May 31, 2022 Regeneron Rips Amgen's 'Bundling Scheme' Amid IP Feud
- April 19, 2022 Wachtell, Goodwin Rep In Regeneron's $250M Biopharma Buy
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS